Evidence map›Paper›PMID 39639395›Full record

ReviewClinical diabetes and endocrinology2024

A systematic review and meta-analysis of the prevalence and risk factors of type 2 diabetes mellitus in Nigeria.

Michael Adeyemi Olamoyegun, Kehinde Alare, Samson Adedeji Afolabi, Nicholas Aderinto, Taiwo Adeyemi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical diabetes and endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Psychological distress, coping methods and self-care among people with diabetes mellitus in Ibadan.Nigerian medical journal : journal of the Nigeria Medical Association
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael Adeyemi OlamoyegunDepartment of Medicine, Endocrinology, Diabetes & Metabolism (EDM) Unit, Ladoke Akintola University of Technology/LAUTECH Teaching Hospital, Ogbomoso, Oyo State, Nigeria. olamoyegunrl@gmail.com.
Kehinde AlareDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Samson Adedeji AfolabiDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Nicholas AderintoDepartment of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Nigeria.
Taiwo AdeyemiDepartment of Medicine, Endocrinology, Diabetes & Metabolism (EDM) Unit, Ladoke Akintola University of Technology/LAUTECH Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is a major global non-communicable disease, leading to increased morbidity and mortality. Its prevalence in Nigeria is driven by various risk factors. This review assesses the national and regional prevalence and risk factors of T2DM in Nigeria.

methodsFollowing PRISMA guidelines, electronic databases (PubMed, Scopus, Google Scholar, African Journals Online) and gray literature were searched for English-language studies. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. Data were extracted with Microsoft Excel and analyzed using Stata version 16 software. Random effect meta-regression analysis at 95% CI was used to assess pooled prevalence and risk factors. Heterogeneity was determined using the I

resultsSixty studies from different Nigerian geopolitical zones met eligibility criteria, with a total sample size of 124,876 participants and a mean age of 48 ± 9.8 years. The pooled prevalence of T2DM in Nigeria was 7.0% (95% CI: 5.0-9.0%). Moderate publication bias was observed. The South-south zone had the highest prevalence at 11.35% (95% CI: 4.52-20.72%), while the North-central zone had the lowest at 2.03% (95% CI: 1.09-3.40%). Significant risk factors included family history (9.73), high socioeconomic status (6.72), physical inactivity (5.92), urban living (4.79), BMI > 25/m

conclusionThe prevalence of T2DM in Nigeria (7.0%) nearly doubled the 2019 International Diabetes Federation estimate (3.7%) and shows a 21.3% increase from the 2019 review. Efforts should focus on modifying identified risk factors to reduce prevalence and prevent complications.

Indexed as

NigeriaPrevalenceReviewRisk factorsType 2 diabetes

Identifiers

PMID39639395
PMCPMC11622640

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.